PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 41 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $20,000 | – | 214,917 | +9143.7% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 2,325 | +75.5% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 1,325 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 1,325 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 1,325 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 1,325 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 1,325 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 1,325 | 0.0% | 0.00% | – |
| Q3 2014 | $1,000 | -91.7% | 1,325 | -90.7% | 0.00% | – |
| Q2 2014 | $12,000 | – | 14,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,226,961 | $221,000 | 0.02% |
| HOME FEDERAL BANK OF TENNESSEE | 100,000 | $10,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 1,077,555 | $107,000 | 0.00% |
| Cutter & CO Brokerage, Inc. | 79,500 | $8,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 81,647 | $8,000 | 0.00% |
| WADE G W & INC | 80,000 | $8,000 | 0.00% |
| PRINCETON CAPITAL MANAGEMENT LLC | 10,000 | $1,000 | 0.00% |
| Virtu KCG Holdings LLC | 364,520 | $36,000 | 0.00% |
| UBS Group AG | 309,214 | $31,000 | 0.00% |
| CITIGROUP INC | 1,000 | $0 | 0.00% |